SK

Subbarao Kattamuri

Active Director Director DIN 00107121
DIN 00107121 First appointment Jul 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Jul 2010
Shareholding value •••• Premium profile

About Subbarao Kattamuri

Data last updated:

Subbarao Kattamuri is a Director at Priche Generics Private Limited (since 2016), Managing Director at Evertogen Life Sciences Limited (since 2013) and Director at Lytica Labs Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹186 Cr; the largest is Priche Generics Private Limited at ₹96.36 Cr (FY 2025). Earlier, Subbarao Kattamuri was a Director at Glochem Industries Private Limited (2020–2025) and Director at Gil Agrotech ( India ) Private Limited (from 2010) and 1 more.

DIN 00107121
Primary Designation Director
Industry Pharma
First Appointment 20 Jul 2010
Oldest Company Age 31 yrs
Largest company Priche Generics Private Limited · ₹96.36 Cr (FY 2025)
Combined revenue ₹186 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Priche Generics Private Limited U74999TG2016PTC112294
Director04 Oct 20162016₹96.36 Cr (FY 2025)Active
Evertogen Life Sciences Limited U24232TG2013PLC085349
Managing Director11 Jan 20132013₹89.28 Cr (FY 2024)Active
Lytica Labs Private Limited U74999TG2017PTC120942
Director01 Dec 20172017₹13.5 Lakh (FY 2025)Active
Director08 Jul 20152002₹6.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glochem Industries Private Limited U24230TG2020PTC146205
Director24 Nov 20202020₹114 Cr (FY 2025)Active
Director20 Jul 20102010Amalgamated
Glochem Industries Private Limited U24110TG1995PTC022303
Managing Director01 Jul 20111995₹58.99 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gil Agrotech ( India ) Private Limited
Glochem Industries Private Limited
Evertogen Life Sciences Limited
K.R.R. Drugs & Intermediates Private Limited
Premium access

Shareholding and investment profile for Subbarao Kattamuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subbarao Kattamuri

Subbarao Kattamuri currently holds 4 directorships: Priche Generics Private Limited (Director, since 04 Oct 2016, revenue ₹96.36 Cr (FY 2025)); Evertogen Life Sciences Limited (Managing Director, since 11 Jan 2013, revenue ₹89.28 Cr (FY 2024)); Lytica Labs Private Limited (Director, since 01 Dec 2017, revenue ₹13.5 Lakh (FY 2025)); K.R.R. Drugs & Intermediates Private Limited (Director, since 08 Jul 2015, revenue ₹6.3 Lakh (FY 2025)).

Subbarao Kattamuri was first appointed on 20 Jul 2010 as Director at Gil Agrotech ( India ) Private Limited. The most recent appointment on record is 24 Nov 2020 at Glochem Industries Private Limited.

The 4 current companies of Subbarao Kattamuri that report revenue have a combined latest revenue of ₹186 Cr: Priche Generics Private Limited ₹96.36 Cr (FY 2025); Evertogen Life Sciences Limited ₹89.28 Cr (FY 2024); Lytica Labs Private Limited ₹13.5 Lakh (FY 2025); K.R.R. Drugs & Intermediates Private Limited ₹6.3 Lakh (FY 2025).

Subbarao Kattamuri held 3 earlier board appointments: Glochem Industries Private Limited (Director, 24 Nov 2020 to 14 Aug 2025); Gil Agrotech ( India ) Private Limited (Director, from 20 Jul 2010); Glochem Industries Private Limited (Managing Director, from 01 Jul 2011).

The current boards of Subbarao Kattamuri's companies include Sushma Kattamuri (Priche Generics Private Limited), Akhila Thotapally (Evertogen Life Sciences Limited), Manav Jassal (Evertogen Life Sciences Limited), Sat Paul Jassal (Evertogen Life Sciences Limited), Sherifuddin Sheriff Shaik (Evertogen Life Sciences Limited), Vikram Ravindra Mamidipudi (Evertogen Life Sciences Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available